Literature DB >> 15928352

Metabolic syndrome and schizophrenia.

Jogin H Thakore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15928352     DOI： 10.1192/bjp.186.6.455

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN： 0007-1250            Impact factor:   9.319


× No keyword cloud information.
  17 in total

1.  A case series: evaluation of the metabolic safety of aripiprazole.

Authors:  Marc De Hert; Linda Hanssens; Ruud van Winkel; Martien Wampers; Dominique Van Eyck; Andre Scheen; Joseph Peuskens
Journal:  Schizophr Bull       Date:  2006-08-29       Impact factor: 9.306

2.  Relationship Between Metabolic Syndrome and Clinical Features, and Its Personal-Social Performance in Patients with Schizophrenia.

Authors:  Omer Saatcioglu; Murat Kalkan; Nurhan Fistikci; Sakire Erek; Kasim Candas Kilic
Journal:  Psychiatr Q       Date:  2016-06

3.  Known and Unexplored Post-Translational Modification Pathways in Schizophrenia.

Authors:  Bradley J Smith; Victor C Carregari
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

4.  Metabolic syndrome in people with schizophrenia: a review.

Authors:  Marc DE Hert; Vincent Schreurs; Davy Vancampfort; Ruud VAN Winkel
Journal:  World Psychiatry       Date:  2009-02       Impact factor: 49.548

5.  S100B Serum Levels in Schizophrenia Are Presumably Related to Visceral Obesity and Insulin Resistance.

Authors:  Johann Steiner; Aye Mu Myint; Kolja Schiltz; Sabine Westphal; Hans-Gert Bernstein; Martin Walter; Matthias L Schroeter; Markus J Schwarz; Bernhard Bogerts
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-06-10

Review 6.  Antipsychotic-induced weight gain in chronic and first-episode psychotic disorders: a systematic critical reappraisal.

Authors:  Mario Alvarez-Jiménez; César González-Blanch; Benedicto Crespo-Facorro; Sarah Hetrick; Jose Manuel Rodríguez-Sánchez; Rocio Pérez-Iglesias; Jose Luis Vázquez-Barquero
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 7.  Osteoporosis, schizophrenia and antipsychotics: the need for a comprehensive multifactorial evaluation.

Authors:  Uriel Halbreich
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

8.  A double blind, placebo-controlled, randomized crossover study of the acute metabolic effects of olanzapine in healthy volunteers.

Authors:  Vance L Albaugh; Ravi Singareddy; David Mauger; Christopher J Lynch
Journal:  PLoS One       Date:  2011-08-09       Impact factor: 3.240

9.  Clozapine impairs insulin action by up-regulating Akt phosphorylation and Ped/Pea-15 protein abundance.

Authors:  Fabio Panariello; Giuseppe Perruolo; Angela Cassese; Ferdinando Giacco; Ginevra Botta; Alessia P M Barbagallo; Giovanni Muscettola; Francesco Beguinot; Pietro Formisano; Andrea de Bartolomeis
Journal:  J Cell Physiol       Date:  2012-04       Impact factor: 6.384

10.  A dominant mutation in Snap25 causes impaired vesicle trafficking, sensorimotor gating, and ataxia in the blind-drunk mouse.

Authors:  Alexander F Jeans; Peter L Oliver; Reuben Johnson; Marco Capogna; Jenny Vikman; Zoltán Molnár; Arran Babbs; Christopher J Partridge; Albert Salehi; Martin Bengtsson; Lena Eliasson; Patrik Rorsman; Kay E Davies
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-05       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.